| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-051-90 | 62135-051 | HUMAN PRESCRIPTION DRUG | Doxazosin mesylate | Doxazosin mesylate | TABLET | ORAL | 20230606 | N/A | ANDA | ANDA075646 | Chartwell RX, LLC | DOXAZOSIN MESYLATE | 1 mg/1 | 90 TABLET in 1 BOTTLE (62135-051-90) |
| 62135-052-90 | 62135-052 | HUMAN PRESCRIPTION DRUG | Doxazosin mesylate | Doxazosin mesylate | TABLET | ORAL | 20230606 | N/A | ANDA | ANDA075646 | Chartwell RX, LLC | DOXAZOSIN MESYLATE | 2 mg/1 | 90 TABLET in 1 BOTTLE (62135-052-90) |
| 62135-053-90 | 62135-053 | HUMAN PRESCRIPTION DRUG | Doxazosin mesylate | Doxazosin mesylate | TABLET | ORAL | 20230606 | N/A | ANDA | ANDA075646 | Chartwell RX, LLC | DOXAZOSIN MESYLATE | 4 mg/1 | 90 TABLET in 1 BOTTLE (62135-053-90) |
| 62135-054-90 | 62135-054 | HUMAN PRESCRIPTION DRUG | Doxazosin mesylate | Doxazosin mesylate | TABLET | ORAL | 20230606 | N/A | ANDA | ANDA075646 | Chartwell RX, LLC | DOXAZOSIN MESYLATE | 8 mg/1 | 90 TABLET in 1 BOTTLE (62135-054-90) |